[vc_row el_id=”post”][vc_column width=”2/3″ el_class=”sideLeftPost”][vc_raw_html el_id=”postImgDestaque”]JTNDZGl2JTIwY2xhc3MlM0QlMjJpbnNlcnRJbnNpZGUlMjIlM0UlM0MlMkZkaXYlM0U=[/vc_raw_html][vc_column_text]Last Tuesday (03), ANVISA – the National Health Surveillance Agency – approved the regulation for products derived from Cannabis sativa, which is the active ingredient in marijuana, excluding the possibility of cultivating the plant in Brazil. The regulation also stipulates that the sale of the product can only be done with a medical prescription.
Cannabis sativa contains two main substances: cannabidiol (CBD) and THC (tetrahydrocannabinol). CBD has been associated with anticonvulsant therapeutic effects for certain types of epilepsy, according to Resolution No. 2.113/14 of the Federal Council of Medicine. However, other therapeutic indications of the substance still require more in-depth scientific studies to confirm them.
The case of THC is different. This substance is primarily responsible for the psychoactive effects of marijuana, and its ability to cause chemical dependency, schizophrenia, anxiety attacks, and depression has already been proven. Impairment of memory and cognitive ability has also been observed.
In Brazil, products derived from Cannabis sativa are generally allowed to contain up to 0,2% THC, according to ANVISA regulations. In this context, effective oversight is essential for patient safety. There are cases like the United Kingdom, where 39% of products were found to contain less than 50% of the amount of CBD described on their labels. Something similar also occurred in the United States, where THC concentrations in such products reached up to 5%, a much higher amount than the permitted limit of 0,3%.
According to Law No. 9.782/1999, in addition to regulation, ANVISA is responsible for the continuous and effective oversight of these products, with a view to protecting the health of the Brazilian population.ADRIANA DA FONTOURA ALVES
A neurologist and lawyer, she holds a Master's degree in Constitutional Law from the Brazilian Institute of Public Law (IDP), where she teaches the subjects of Forensic Medicine and Law and Bioethics.[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][vc_column width=”1/4″ el_class=”sideRightPost”][vc_widget_sidebar sidebar_id=”sidebar”][/vc_column][/vc_row][vc_row full_width=”stretch_row” equal_height=”yes” el_id=”courses-page-box-5″ css=”.vc_custom_1526064800224{margin-top: 0px !important;margin-bottom: 0px !important;background-image: url(http://homologacao.idp.edu.br/wp-content/uploads/2018/02/bn_contato_idp-1980×300-1.jpg?id=5274) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” el_class=”postCTA”][vc_column][themeum_action alignment=”left” title=”STILL HAVE QUESTIONS?” title_style=”customstyle” title_heading=”h2″ title_size=”20″ title_color=”#ffffff” title_weight=”800″ title_margin=”53px 0 0″ title_padding=”0″ btn_position=”btnright” btntext=”CONTACT US” btnurl=”/contact/” btntype=”white” btnsize=”btn-lg”][/vc_column][/vc_row]
